Kadant Declares Cash Dividend

WESTFORD, Mass.--(BUSINESS WIRE)-- Kadant Inc. (NYS: KAI) announced that its Board of Directors has approved a quarterly cash dividend to stockholders of $0.125 per share to be paid on August 8, 2013 to stockholders of record as of the close of business on July 11, 2013. Future declarations of dividends are subject to Board approval and may be adjusted as business needs or market conditions change.

Kadant Inc. is a leading supplier to the global pulp and paper industry. Our stock-preparation; fluid-handling; and doctoring, cleaning, and filtration products are designed to increase efficiency and improve quality in pulp and paper production. Many of our products, particularly in our Fluid-Handling product line, are also used to optimize production in other process industries. In addition, we produce granules from papermaking byproducts for agricultural and lawn and garden applications. Kadant is based in Westford, Massachusetts, with revenues of $332 million in 2012 and 1,600 employees in 17 countries worldwide. For more information, visit www.kadant.com.

The following constitutes a "Safe Harbor" statement under the Private Securities Litigation Reform Act of 1995: This press release contains forward-looking statements that involve a number of risks and uncertainties, including forward-looking statements about our business, financial performance and cash dividend program. Our actual results may differ materially from these forward-looking statements as a result of various important factors, including those set forth under the heading "Risk Factors" in Kadant's quarterly report on Form 10-Q for the period ended March 30, 2013. These include risks and uncertainties relating to our dependence on the pulp and paper industry; significance of sales and operation of manufacturing facilities in China; commodity and component price increases or shortages; international sales and operations; competition; soundness of suppliers and customers; our effective tax rate; future restructurings; soundness of financial institutions; our debt obligations; restrictions in our credit agreement; our acquisition strategy; protection of patents and proprietary rights; failure of our information systems or breaches of data security; fluctuations in our share price; and anti-takeover provisions. We undertake no obligation to publicly update any forward-looking statement, whether as a result of new information, future events, or otherwise.

Rosen Law Firm Announces Investigation of rue21, Inc. in Connection with its Sale to Apax Partners - RUE

NEW YORK--(BUSINESS WIRE)-- The Rosen Law Firm is investigating the Board of Directors of rue21, Inc. (NAS: RUE) for possible breaches of fiduciary duty and other violations of state law in connection with its sale of the Company to Apax Partners, a private equity firm.

If you would like to join the action please email or call Phillip Kim or Kevin Chan, toll-free, at 866-767-3653; or email at pkim@rosenlegal.com or kchan@rosenlegal.com. There is no cost or obligation to you.

Under the terms of the transaction, shareholders will receive $42.00 for each share of rue21 stock they own. The SKM II funds, which own approximately 30% of rue21's outstanding shares and are associated with Apax Partners, have agreed to vote in favor of the transaction. The investigation relates to whether the price of $42.00 per share is fair to public shareholders and whether rue21's Board breached its fiduciary duties in connection with the transaction.

If you own rue21 common stock and wish to obtain additional information, you may contact Phillip Kim or Kevin Chan of The Rosen Law Firm toll free at 866-767-3653 or via e-mail at pkim@rosenlegal.com or kchan@rosenlegal.com.

The Rosen Law Firm represents investors throughout the globe, concentrating its practice in securities class actions and shareholder derivative litigation.

Attorney Advertising. Prior results do not guarantee a similar outcome.

DEADLINE TOMORROW: Levi & Korsinsky Notifies Investors with Losses on Their Investment in Avid Technology, Inc. of Class Action Lawsuit and the Deadline of May 24, 2013 to Seek a Lead Plaintiff Position

NEW YORK--(BUSINESS WIRE)-- Levi & Korsinsky announces that a class action lawsuit has been commenced in the United States District Court for the District of Massachusetts on behalf of investors who acquired Avid Technology, Inc. ("Avid" or "the Company") (NAS: AVID) stock between April 22, 2011 and February 22, 2013.

For more information, click here: http://zlk.9nl.com/avid-technology/.

The Complaint alleges that throughout the Class Period defendants made false and/or misleading statements or failed to disclose materially adverse facts about the Company's business, operations and prospects. Specifically, defendants misrepresented or failed to disclose that: (a) the Company incorrectly accounted for its Software Updates by failing to properly treat the Software Updates as post-contract customer support under U.S. Generally Accepted Accounting Principles; (b) the Company lacked adequate internal and financial controls; and (c) as a result of the foregoing, the Company's statements were materially false and misleading at all relevant times.

If you suffered a loss in Avid you have until May 24, 2013to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn't require that you serve as a lead plaintiff. To obtain additional information, contact Joseph E. Levi, Esq. either via email at jlevi@zlk.com or by telephone at (877) 363-5972, or visit http://zlk.9nl.com/avid-technology/.

Levi & Korsinsky is a national firm with offices in New York, New Jersey and Washington D.C. The firm has extensive expertise in prosecuting securities litigation involving financial fraud, representing investors throughout the nation in securities and shareholder lawsuits. Attorney advertising. Prior results do not guarantee similar outcomes.

Hormel Foods Donates Three Semitrailers of Product for Tornado Relief Efforts in Oklahoma

AUSTIN, Minn.--(BUSINESS WIRE)-- Hormel Foods Corporation (NYS: HRL) today announced a donation of three semitrailer loads of product to assist with tornado relief efforts in Oklahoma. The donation of 165,000 Hormel^®Compleats^® microwave meals will go to Feeding America food banks in Oklahoma City and its surrounding suburbs.

"Our thoughts and prayers are with all who were affected by this devastating tornado," said Julie H. Craven, vice president of corporate communications at Hormel Foods. "We hope to provide a helpful way to feed the many in need as the difficult process of rebuilding begins."

Hormel ^® Compleats ^® microwave meals are 10-ounce satisfying meals that feature quality chicken, beef or turkey as well as flavorful vegetables and pasta, potatoes or rice. Convenient for relief efforts, they are a source of protein, do not need to be frozen or refrigerated and can be microwaved in the tray in 60 seconds. Additionally, these meals are fully cooked and can be eaten straight from the package for those without access to electricity.

About Hormel Foods
Hormel Foods Corporation, based in Austin, Minn., is a multinational manufacturer and marketer of consumer-branded food and meat products, many of which are among the best known and trusted in the food industry. The company leverages its extensive expertise, innovation and high competencies in pork and turkey processing and marketing to bring branded, value-added products to the global marketplace. The company is a member of the Standard & Poor's (S&P) 500 Index, S&P Dividend Aristocrats for 2012, Maplecroft Climate Innovation Indexes, Global 1000 Sustainable Performance Leaders and was again named one of "The 100 Best Corporate Citizens" by Corporate Responsibility Magazine for the fifth year in a row. Hormel Foods debuted on the G.I. Jobs magazine list of America's Top 100 Military Friendly Employers in 2012. The company enjoys a strong reputation among consumers, retail grocers, foodservice and industrial customers for products highly regarded for quality, taste, nutrition, convenience and value. For more information, visit http://www.hormelfoods.com.

ADTRAN Applauds the $485 Million FCC Connect America Fund Order Spurring Additional Broadband Investment

Interim FCC Chairman Clyburn issues order for funds to enable greater access to high-speed broadband for all Americans

HUNTSVILLE, Ala.--(BUSINESS WIRE)-- ADTRAN®, Inc., (NAS: ADTN) , a leading provider of next-generation networking solutions, announced its support for the FCC and Interim FCC Chairman Mignon Clyburn's actions to make $485 million available in the second round CAF Phase 1 Order issued today. The new order provides $300 million of 2013 funding for unserved and underserved broadband infrastructure investment. It also makes available the $185 million of first round CAF Phase 1 funds that were unclaimed in 2012.

In this order, the FCC addressed many of the issues that have held back acceptance of first round CAF funding and additional CapEx investments by broadband service providers. As a result, several of the top price cap carriers have committed to match these funds with private investment. This week's actions by the FCC will enable U.S. broadband carriers to build out the infrastructure needed to deploy high-speed broadband services in rural communities across the country.

"ADTRAN applauds the efforts of Interim FCC Chairman Clyburn and the FCC to address CAF Phase 1 funding rules and the FCC's recent progress on the CAF Phase 2 program. U.S. carriers now have access to funding that can be leveraged with private investment to build out broadband infrastructure for unserved and underserved communities across our country," said Tom Stanton, chairman and chief executive officer for ADTRAN.

About ADTRAN

ADTRAN, Inc. is a leading global provider of networking and communications equipment. ADTRAN's products enable voice, data, video and Internet communications across a variety of network infrastructures. ADTRAN solutions are currently in use by service providers, private enterprises, government organizations, and millions of individual users worldwide. For more information, please visit www.adtran.com.

Bon Secours Health System Renews Relationship with MedAssets to Build Upon $25 Million in Financial and Revenue Cycle Performance Improvement

Not-for-profit health system's focus on charge and reimbursement processes drives greater revenue capture, reimbursement and increased compliance

ATLANTA--(BUSINESS WIRE)-- MedAssets (NAS: MDAS) today announced that Maryland-based Bon Secours Health System (Bon Secours) has elected to renew its relationship with the company to drive continued financial performance improvement. The agreement builds upon the health system's 2012 success in utilizing MedAssets Revenue Cycle Technology and consulting services to realize more than $25 million in increased net revenue through automation, streamlined processes and better control over operating margins in day-to-day operations.

"With steadily shrinking margins and the impending impact of the ICD-10 transition, it is imperative to implement best practices that support improved data accuracy, facilitate transparency and generate increased profitability," said Joe Ingold, vice president, Revenue Cycle, Bon Secours Health System. "Leveraging MedAssets proven technology and expertise complements the clinical and operational benefits from our enterprise-wide Epic conversion and creates a solid foundation for long-term financial success."

Driving Improved Financial Results for Sustainable Growth

Bon Secours' 2012 financial improvements were achieved as the health system progressed in its multi-year, multi-facility installation of Epic solutions to support the organization's overall mission and goals of delivering safe, high quality care while containing costs. MedAssets CrossWalk® solution supported an initiative to integrate supply costs with charge data, which resulted in a $6.4 million increase in net revenue. CrossWalk also supported Bon Secours to realign medical supply and device implant pricing, which contributed another $7 million in net revenue improvement. Other 2012 results include a more than $10 million net revenue increase through MedAssets Claims Management and Charge Capture Audit® solutions. A long-term MedAssets client, Bon Secours also leverages MedAssets CDM Master® solution to help drive system-wide standardization and maintain accurate and compliant charging protocols.

"We are pleased by the benefits Bon Secours Health System has realized to date and are honored to continue to support its efforts to optimize operational and financial performance," said Greg Strobel, president, Revenue Cycle Management, MedAssets. "Less funding and reimbursement means every healthcare provider must find a way to make innovative changes to improve the bottom line. MedAssets can bring swift and measurable benefits to an organization through technology solutions and consulting services that cover the full spectrum of providers' revenue cycle needs—from patient access to claims denials—along with capabilities to drive process improvement throughout the materials management cycle from purchasing to billing."

About Bon Secours Health System

Bon Secours Health System, Inc., based in Marriottsville, Maryland, is a $3.5 billion not-for-profit Catholic health system that owns, manages or joint ventures 19 acute care, 5 long term care, 4 assisted living, 6 retirement communities/senior housing, 14 home care and hospice services, and other facilities, primarily on the East Coast. Bon Secours Health System consists of more than 21,000 caregivers helping people in six states. Its vision is to be a prophetic Catholic health ministry partnering with communities to create a more humane world, build health and social justice and provide exceptional value for those served. For more information, please visit www.bshsi.com.

About MedAssets

MedAssets (NAS: MDAS) helps healthcare organizations to improve financial strength through innovative revenue cycle, spend and clinical resource management solutions that enable improved margins, cash flow, quality of care and patient satisfaction. More than 4,200 hospitals and 122,000 non-acute healthcare providers currently use the company's Web-based technologies and evidence-based solutions to help capture revenue, control cost, increase regulatory compliance and optimize operational efficiency to improve the care delivery process. As a result, the company manages annually more than $50 billion in healthcare supply spend and touches over $365 billion in gross patient revenues. For more information, please visit www.medassets.com.

MDAS/B

Aetna Announces Appearance at the Deutsche Bank 38 ^th Annual Health Care Conference

HARTFORD, Conn.--(BUSINESS WIRE)-- Aetna (NYSE: AET) announced today that Shawn M. Guertin, senior vice president and CFO, is scheduled to make a presentation at the Deutsche Bank 38^th Annual Health Care Conference on May 30, 2013, in Boston.

Aetna's presentation is scheduled to begin at 9:20 a.m. ET. Investors, analysts and the general public are invited to listen to this presentation over the Internet via Aetna's Investor Information link at www.aetna.com/investor. To listen to this presentation live on the Internet, visit Aetna's website prior to the presentation to download and install any necessary audio software. A webcast replay will be available via Aetna's Investor Information link at www.aetna.com/investor, beginning approximately two hours after the event, for 14 days.

Anyone listening to the presentation is encouraged to read Aetna's annual and quarterly reports filed with the Securities and Exchange Commission for a discussion of Aetna's historical results of operations and financial condition. Information reconciling certain financial and other measures that may be disclosed in the presentation to relevant GAAP measures will be available prior to the presentation via the Investor Information portion of Aetna's website.

About Aetna

Aetna is one of the nation's leading diversified health care benefits companies, serving an estimated 44 million people with information and resources to help them make better informed decisions about their health care. Aetna offers a broad range of traditional, voluntary and consumer-directed health insurance products and related services, including medical, pharmacy, dental, behavioral health, group life and disability plans, and medical management capabilities, Medicaid health care management services, workers' compensation administrative services and health information technology services. Aetna's customers include employer groups, individuals, college students, part-time and hourly workers, health plans, health care providers, governmental units, government-sponsored plans, labor groups and expatriates. For more information, see www.aetna.com.

Advantest Earns 25th Consecutive Ranking as a Top Semiconductor Test Equipment Supplier in the Annual VLSIresearch Customer Satisfaction Survey

... Global IC test equipment supplier recognized by customers for technical leadership, product performance, quality of results, and other achievements

TOKYO--(BUSINESS WIRE)-- Leading semiconductor test equipment supplier Advantest Corporation (TSE: 6857, NYSE: ATE) announced today that it has earned a place on the VLSIresearch list of the 10 BEST Suppliers for 2013. For the 25^th consecutive year, ratings from the world's leading producers of semiconductors -IDMs, OSATs and Fabless companies - have secured Advantest a position on the time-honored survey conducted by leading industry-analyst firm, VLSIresearch inc (Santa Clara, Calif.).

Specific areas in which Advantest's customers expressed their greatest degree of satisfaction with the company's performance included, trust in supplier, product performance, quality of results, technical leadership, and partnering. The industry's highest ratings were awarded to Advantest in the categories of trust, partnering, field engineering support, commitment, and support after sales.

"With its ranking on the 10 BEST Supplier list for 2013, Advantest now holds the distinction of being named to the list for a quarter century, and in each year since the survey's inception in 1988," said G. Dan Hutcheson, CEO of VLSIresearch. "Twenty-five years of sustained recognition is quite a testament to Advantest's commitment, technical leadership and strength of management."

The annual customer satisfaction survey collects feedback from more than 98% of the worldwide chip market. Participants are asked to rate equipment suppliers among fifteen categories based on three key factors: supplier performance, customer service, and product performance. In total, over 70,000 responses were tallied into the results. The annual VLSIresearch Customer Satisfaction Survey on Chip Making Equipment is the only publicly available opportunity since 1988 for chip manufacturers to provide feedback on their suppliers.

"Advantest takes pride in the high standards it sets for its products and services and we are gratified that our commitment to excellence is so highly recognized by the world's leading semiconductor manufacturers," stated Haruo Matsuno, president and CEO of Advantest Corporation. "We are grateful to our customers for the trust and confidence they place in our capabilities and we remain steadfastly focused on their success and to delivering the industry's highest performing test solutions," he continued.

About VLSIresearch

VLSIresearch is an award-winning provider of market research and economic analysis on the technical, business, and economic aspects within semiconductor, nanotechnology, and related industries. VLSIresearch provides intelligence for faster and better decision making in the areas of semiconductors, photovoltaics, LEDs display, manufacturing, materials, and critical subsystems. VLSIresearch was founded in 1976. More information is available at: www.VLSIresearch.com

About Advantest Corporation

A world-class technology company, Advantest is the leading producer of automatic test equipment (ATE) for the semiconductor industry and a premier manufacturer of measuring instruments used in the design and production of electronic instruments and systems. Its leading-edge systems and products are integrated into the most advanced semiconductor production lines in the world. The company also focuses on R&D for emerging markets that benefit from advancements in nanotech and terahertz technologies, and has recently introduced multi-vision metrology scanning electron microscopes essential to photomask manufacturing, as well as groundbreaking 3D imaging and analysis tools. Founded in Tokyo in 1954, Advantest established its first subsidiary in 1982, in the USA, and now has subsidiaries worldwide. More information is available at www.advantest.com.